- Home
- SRPT vs VOR Comparison
SRPT vs VOR Comparison
Compare SRPT & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SRPT | VOR |
|---|---|---|
| Founded | 1980 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 207.1M |
| IPO Year | 1997 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SRPT | VOR |
|---|---|---|
| Price | $21.28 | $11.63 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 29 | 9 |
| Target Price | $26.23 | ★ $66.63 |
| AVG Volume (30 Days) | 2.8M | ★ 3.6M |
| Earning Date | 11-03-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,413,715,000.00 | N/A |
| Revenue This Year | $13.72 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 47.15 | N/A |
| 52 Week Low | $10.42 | $2.62 |
| 52 Week High | $129.84 | $65.80 |
Technical Indicators
Market Signals| Indicator | SRPT | VOR |
|---|---|---|
| Relative Strength Index (RSI) | 50.54 | 44.77 |
| Support Level | $21.36 | $12.26 |
| Resistance Level | $22.52 | $15.00 |
| Average True Range (ATR) | 0.95 | 1.76 |
| MACD | -0.08 | 0.18 |
| Stochastic Oscillator | 40.66 | 0.00 |
Price Performance
Historical ComparisonAbout SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.